Literature DB >> 22729453

General relationship between transit compartments and lifespan models.

Gilbert Koch1, Johannes Schropp.   

Abstract

Transit compartment models (TCM) are important tools in pharmacokinetic/pharmacodynamic (PKPD) modeling. In this work we investigate the relationship between TCMs with arbitrary initial values and lifespan models (LSM) with non-constant past and constant lifespan. We show that the total population in all transit compartments converges to a LSM, if the number of compartments n tends to infinity. The key to obtain this result is to establish a relationship between the initial values of the TCM and the non-constant past of the LSM. We apply the result to two already published PKPD models.

Mesh:

Year:  2012        PMID: 22729453     DOI: 10.1007/s10928-012-9254-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  12 in total

1.  Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.

Authors:  L A Harker; L K Roskos; U M Marzec; R A Carter; J K Cherry; B Sundell; E N Cheung; D Terry; W Sheridan
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

Review 2.  Mechanistic models for myelosuppression.

Authors:  Lena E Friberg; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

3.  Comparative performance of cell life span and cell transit models for describing erythropoietic drug effects.

Authors:  Nageshwar R Budha; Andreas Kovar; Bernd Meibohm
Journal:  AAPS J       Date:  2011-10-18       Impact factor: 4.009

4.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.

Authors:  Y N Sun; W J Jusko
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

Review 5.  Lifespan based indirect response models.

Authors:  Wojciech Krzyzanski; Juan Jose Perez Ruixo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-03       Impact factor: 2.745

6.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

7.  Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibody.

Authors:  Gilbert Koch; Thomas Wagner; Christine Plater-Zyberk; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-23       Impact factor: 2.745

8.  Modeling of tumor growth and anticancer effects of combination therapy.

Authors:  Gilbert Koch; Antje Walz; Gezim Lahu; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-22       Impact factor: 2.745

9.  Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents.

Authors:  Monica Simeoni; Paolo Magni; Cristiano Cammia; Giuseppe De Nicolao; Valter Croci; Enrico Pesenti; Massimiliano Germani; Italo Poggesi; Maurizio Rocchetti
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.

Authors:  Kevin J Freise; John A Widness; Robert L Schmidt; Peter Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-06-14       Impact factor: 2.745

View more
  4 in total

1.  Solution and implementation of distributed lifespan models.

Authors:  Gilbert Koch; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-11-01       Impact factor: 2.745

2.  Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.

Authors:  Gilbert Koch; Wojciech Krzyzanski; Juan Jose Pérez-Ruixo; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-21       Impact factor: 2.745

3.  Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeutics.

Authors:  Gary Mo; Frank Gibbons; Patricia Schroeder; Wojciech Krzyzanski
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  Exact solutions and equi-dosing regimen regions for multi-dose pharmacokinetics models with transit compartments.

Authors:  F Hof; L J Bridge
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-10-10       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.